| |
Securities (Disclosure of Interests) Daily Summaries
|
| |
SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - PRINTED: 24/05/01 PAGE: 1
DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
(GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)
STOCK NAME : Cafe de Coral H (00341)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
LO PIK LING ANITA G ORD CAFE DE CORAL HOLDINGS LTD. 400,000 010403-310312 2.950 1
STOCK NAME : Catic Int'l (00232)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
REN HAIFENG E ORD CATIC INTERNATIONAL HOLDINGS L- 5,400,000 - - 0
TD
STOCK NAME : Chevalier Cons (00579)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
WONG KIE NGOK ALEXANDER G OPT CHEVALIER INT'L HOLDINGS LTD 1,200,000 040998-030901 0.538 1
G OPT CHEVALIER INT'L HOLDINGS LTD 5,000,000 300600-290603 0.488 1
TAM KWOK WING G OPT CHEVALIER INT'L HOLDINGS LTD 1,700,000 040998-030901 0.538 1
G OPT CHEVALIER INT'L HOLDINGS LTD 5,000,000 300600-290603 0.488 1
STOCK NAME : HK Pharma (00182)
Director/Chief Executive G/E Class Company Name Quantity Exercise Period Ex. Price Consideration Note
------------------------------------ --- --------------- ------------------------------- ------------------ --------------- ---------- --------------- -----------
SUN HIU LU G ORD HONG KONG PHARMACEUTICAL HOLDI- 27,000,000 160500-150503 0.639 1
NGS LIMITED
CHU KWAN G ORD HONG KONG PHARMACEUTICAL HOLDI- 25,200,000 160500-150503 0.639 1
NGS LIMITED
G ORD HONG KONG PHARMACEUTICAL HOLDI- 1,000,000 301000-291003 0.460 1
NGS LIMITED
SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES - PRINTED: 24/05/01 PAGE: 2
DIRECTORS'/CHIEF EXECUTIVES' NOTIFICATIONS REPORT - B
(GRANTS, ASSIGNMENTS AND EXERCISES OF RIGHTS)
***** END OF REPORT *****
NOTES:
N1 Please refer to the Company's announcement of 31/01/01.
N2 During the financial restructuring of Hong Kong Pharmaceutical
Holdings Limited ("HKP') as announced on 7 March 2000, HKP entered
into a subscription agreement with a creditor (the "Creditor")
pursuant to which HKP agreed to issue to the Creditor a convertible
note in an aggregate principal sum of HK$13 million (the "Note")
which entitle the holder of the Note to exercise the conversion
rights attached to the Note and convert into the ordinary shares of
HKP at the conversion price of HK$0.10 each. The Creditor also
entered into an option agreement with Hong Tau Investment Ltd ("Hong
Tau") (the "Option Agreement") whereby the Creditor has agreed to
grant to Hong Tau a first right of refusal for the acquisition of any
conversion shares at HK$0.10 if the Creditor wishes to sell them.
On 27 April 2001, HKP allot and issue 130,000,000 conversion shares
to the Creditor pursuant to the Note and the Creditor had disposed of
130,000,000 conversion shares to Wai Fat International Limited, a
wholly owned subsidiary of Hong Tau, on 21 May 2001 pursuant to the
Option Agreement.
N3 Exercise of share option
N4 Appointed as a director of the Company on 18/05/01.
N5 Consideration per unit : $0.85 - $0.86
N6 Disposals were made from 17/05/01 to 22/05/01 at prices ranging from
$1.48 to $1.53 per share.
N7 Scrip Dividend
N8 1,001,227 shares were acquired by Billion Up Limited ("Billion Up") on
19th May, 2001 at HK$0.10 each. The aggregate of direct and indirect
interests after the said event remains unchanged. The interests
included:
a. The direct interests in 2,159,475,904 shares held by Billion
Up, a wholly-owned subsidiary of Chinese Estates Holdings Ltd
("Chinese Estates"); and
b. The indirect interests in 60,524,096 shares derived from the
obligation of Billion Up or Chinese Estates to purchase or procure
purchases of these shares at HK$0.10 each upon exercise of put
options by the scheme creditors pursuant to the scheme of arrange-
ment of Chi Cheung Investment Company Limited effective on 6th
November, 2000 within 6 months from 20th November, 2000.
Billion Up ceased to have indirect interests in 60,524,096 shares as
the obligation of Billion Up or Chinese Estates to purchase or procure
purchase of those 60,524,096 shares was ceased on 20th May, 2001
following expiry and lapse of the respective put options referred
above. The aggregate of interests after the said event decreases to
and includes only the direct interests in 2,159,475,904 shares held
by Billion Up.
N9 898,098 warrants were acquired by Billion Up Limited ("Billion Up")
on 19th May, 2001 at HK$0.01 each upon exercise of put options by the
scheme creditor. The aggregate of direct and indirect interests after
the said event remains unchanged. The interests include:
a. the direct interests in 383,527,348 warrants held by Billion Up;
and
b. the indirect interests in 60,733,720 warrants derived from the
obligation of Billion Up and Chinese Estates Holdings Limited
("Chinese Estates") to purchase or procure purchase of the
warrants at HK$0.01 each upon exercise of put options by the
scheme creditors pursuant to the scheme of arrangement of
Chi Cheung Investment Co Ltd effective on 6th November,
2000 within 6 months from 20th November, 2000. Billion Up
is a wholly-owned subsidiary of Chinese Estates and Mr.
Joseph Lau has deemed interests in Chinese Estates.
Billion Up ceased to have indirect interests in 60,733,720 warrants
as the obligation of Billion Up or Chinese Estates to purchase or
procure purchase of those 60,733,720 warrants was ceased on 20th
May, 2001 following expiry and lapse of the respective put options
referred above. The aggregate of interests after the said event
decreases to and includes only the direct interests in 383,527,348
warrants held by Billion Up.
N10 Billion Up Limited ("Billion Up") ceased to have indirect interests
in 60,524,096 shares as the obligation of Billion Up or Chinese
Estates Holdings Limited to purchase or procure purchase of those
60,524,096 shares was ceased on 20th May, 2001 following expiry and
lapse of the respective put options. The aggregate of interests
after the said event decreases to and includes only the direct
interests in 2,159,475,904 shares held by Billion Up.
N11 Revised
N12 SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES
SUBSTANTIAL SHAREHOLDERS' NOTIFICATIONS REPORT
Stock Name: Manulife Financial Corporation (stock code: 945)
*ISC as at 21/05/01 : 482,165,381
The Securities and Futures Commission has granted Manulife Financial
Corporation ("MFC") a partial exemption from compliance with the
Securities (Disclosure of Interests) Ordinance pursuant to guidelines
published under section 2A of the Ordinance. Under the partial
exemption, MFC is not required to prepare registers, maintain records
or file, and MFC's corporate insiders are not required to file, with
Hong Kong regulatory authorities disclosure of interest reports
pursuant to the Ordinance on the condition that MFC will file with
the SEHK disclosures of interests made in Canada and the U.S. where
it maintains primary listings.
1. Under Canadian law, 10% shareholders of MFC have to file reports
to the Ontario Securities Commission ("OSC"). Reports made by 10%
shareholders, if any, can be found in OSC website www.sedar.com.
MFC has agreed to monitor the OSC Weekly Bulletin and Insider
Early Warning Report Press Releases every two weeks and if any
reports by or concerning 10% shareholders and filed, MFC will
provide a hard copy to the SEHK for inspection by the Hong Kong
public. So far, the SEHK has not received any such reports from
MFC.
2. Under U.S. law, 5% shareholders of MFC have to file reports to
the U.S. Securities and Exchange Commission ("SEC") pursuant to
Schedule 13G/13D of the Securities and Exchange Act 1934 of the
United States. Up-to-date reports made by 5% shareholders, if
any, can be found in SEC website at www.sec.gov. MFC has agreed
to monitor the SEC website every two weeks and if any reports on
5% shareholders are filed, MFC will provide a hard copy to the
SEHK for inspection by the Hong Kong public. So far, the SEHK
has not received any such reports from MFC.
3. Hard copies of filings or reports provided by MFC under paragraphs
1 and 2 above (if any) are available for inspection at the SEHK's
office at 11/F., One International Finance Centre, 1 Harbour View
Street, Central, Hong Kong, and upon request in writing to MFC at
MFC's office at Manulife Plaza, The Lee Gardens, 48th Floor, 33
Hysan Avenue, Causeway Bay, Hong Kong. For enquiries or arrange-
ments regarding inspection at the SEHK please contact the SEHK
SDI Unit (Mr. Chan (2840-3707) or Miss Tsui (2840-3769)).
* ISC refers to the latest Issued Share Capital of the listed company
recorded by the Exchange as at the date of this summaries. It might
not promptly reflect changes caused by share placements, rights
issue, bonus issue, etc. Readers should exercise caution when using
these figures.
N13 SECURITIES (DISCLOSURE OF INTERESTS) DAILY SUMMARIES
DIRECTORS' AND CHIEF EXECUTIVES' NOTIFICATIONS REPORT
Stock Name: Manulife Financial Corporation (stock code: 945)
*ISC as at 21/05/01 : 482,165,381
The Securities and Futures Commission has granted Manulife Financial
Corporation ("MFC") a partial exemption from compliance with the
Securities (Disclosure of Interests) Ordinance pursuant to guidelines
published under section 2A of the Ordinance. Under the partial
exemption, MFC is not required to prepare registers, maintain records
or file, and MFC's corporate insiders are not required to file, with
Hong Kong regulatory authorities disclosure of interest reports
pursuant to the Ordinance on the condition that MFC will file with
the SEHK disclosures of interests made in Canada and the U.S. where
it maintains primary listings.
1. Under Canadian law, "insiders" including directors of MFC have
to file reports to the Ontario Securities Commission ("OSC")
in Form 55 pursuant to the Ontario Securities Act. No Form 55
filings have been made by MFC today.
2. MFC is presently a "foreign private issuer" under U.S. law. As
such, no directors of MFC are required to make any disclosure of
interests filings under the Securities Exchange Act 1934 of the
United States.
* ISC refers to the latest Issued Share Capital of the listed company
recorded by the Exchange as at the date of this summaries. It
might not promptly reflect changes caused by share placements,
rights issue, bonus issue, etc. Readers should exercise caution
when using these figures.
| |